VCs that need to raise money in 2009 or 2010 may find the going rough. Here we chart out when life sciences VCs raised their last funds.
Venture capitalists typically raise new funds about every three years. But some firms that planned to re-up in 2008-2009 have run into trouble.
START-UP has tracked fundraising disclosed by health care venture capitalists (as opposed to diversified funds that also invest in IT or clean tech) that have previously raised funds of $150...
In this week's episode: a preview of major ASCO readouts; Roivant stays patient in deals; Lilly diversifies pain pipeline with SiteOne acquisition; Nucala gets US COPD nod; and women in Indian pharma.
In a study intended to show similar benefit in western patients, PD-1/VEGF-targeting ivonescimab met a progression-free survival endpoint, but missed on OS.
One Phase III trial hits but a second study misses by a mile.
